A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients

Clinical trial NCT02279407 · COMPLETED

Trial details

NCT number: NCT02279407
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)

Start date: 2015-01-01
Primary completion: 2015-12-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.